N05.5: Sindrom Nefritik yang Tidak Spesifik dengan Glomerulonefritis Mesangiokapiler Difus

1. Johnson RJ, Feehally J, Floege J. Comprehensive Clinical Nephrology. 6th ed. Philadelphia: Elsevier; 2019.

2. Alpers CE, Chang A. Robbins and Cotran Pathologic Basis of Disease. 10th ed. Philadelphia: Elsevier; 2021.

3. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney International Supplements. 2021;11(2):1-274.

4. Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis: Pathogenetic heterogeneity and proposal of a new classification. Semin Nephrol. 2020;40(3):256-268.

5. Masani NN, Jhaveri KD, Fishbane S. Update on membranoproliferative GN. Clin J Am Soc Nephrol. 2022;17(5):755-766.

6. World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems. 10th Revision. Geneva: WHO; 2019.

7. Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD Atlas of Renal Pathology: Membranoproliferative glomerulonephritis. Am J Kidney Dis. 2019;74(3):e9-e12.

8. Smith RJH, Harris CL, Pickering MC. Dense deposit disease. Clin Immunol. 2021;223:108649.

9. Ravindran A, Fervenza FC, Smith RJH, Sethi S. C3 glomerulopathy: Ten years' experience at a single center. Kidney Int. 2018;94(4):792-800.

10. Hou J, Markowitz GS, Bomback AS, et al. Toward a working definition of C3 glomerulopathy by immunofluorescence. Kidney Int. 2020;97(3):515-524.